Atai life sciences presents pharmacodynamic data on grx-917 in a late breaking poster presentation at the 2023 sobp annual meeting

- pharmacodynamic profile of grx-917 indicates potential for anxiolytic activity without the significant sedative side effects associated with benzodiazepines

ATAI Ratings Summary

ATAI Quant Ranking